Evan Seigerman
Stock Analyst at BMO Capital
(4.53)
# 986
Out of 4,495 analysts
989
Total ratings
54.7%
Success rate
8.2%
Average return
Main Sectors:
Stocks Rated by Evan Seigerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $600 | $496.50 | +20.85% | 68 | Jul 7, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $39.00 | $37.69 | +3.48% | 1 | Jul 6, 2026 | |
| AMGN Amgen | Maintained: Buy | $400 | $363.62 | +10.00% | 67 | Jun 30, 2026 | |
| REPL Replimune Group | Upgraded: Buy | $1 → $16 | $11.11 | +44.01% | 31 | Jun 30, 2026 | |
| TSHA Taysha Gene Therapies | Maintained: Buy | $14 | $6.57 | +113.09% | 9 | Jun 30, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $135 | $125.07 | +7.94% | 46 | Jun 23, 2026 | |
| PFE Pfizer | Maintained: Buy | $34 | $24.25 | +40.21% | 52 | Jun 23, 2026 | |
| INCY Incyte | Upgraded: Hold | $75 → $94 | $118.52 | -20.69% | 51 | Jun 22, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | $45 | $48.88 | -7.94% | 49 | Jun 22, 2026 | |
| ABBV AbbVie | Maintained: Buy | $258 | $249.91 | +3.24% | 26 | Jun 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $196 | $198.91 | -1.46% | 61 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $7.29 | -3.98% | 10 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,300 | $1,216.95 | +6.82% | 116 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $55.14 | +162.97% | 20 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $78.94 | +26.68% | 30 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $730 | $667.95 | +9.29% | 76 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $60 | $57.94 | +3.56% | 66 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $34 | $26.41 | +28.74% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $144 | $180.55 | -20.24% | 45 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 | $92.98 | +37.66% | 13 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $24 | $16.79 | +42.94% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $174 | $134.84 | +29.04% | 76 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $57.94 | +20.81% | 9 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $72 → $112 | $137.64 | -18.63% | 4 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $42.84 | - | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.54 | - | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.29 | n/a | 1 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €115.51 → €131.27 | $139.60 | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.89 | n/a | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.11 | n/a | 3 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $27 | $5.90 | n/a | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €135.00 → €129.00 | $26.64 | n/a | 6 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.69 → $0.84 | $1.36 | n/a | 6 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $30 | $4.57 | n/a | 4 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $169 → $220 | $30.59 | n/a | 2 | Feb 24, 2020 |
Vertex Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $600
Current: $496.50
Upside: +20.85%
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $39.00
Current: $37.69
Upside: +3.48%
Amgen
Jun 30, 2026
Maintained: Buy
Price Target: $400
Current: $363.62
Upside: +10.00%
Replimune Group
Jun 30, 2026
Upgraded: Buy
Price Target: $1 → $16
Current: $11.11
Upside: +44.01%
Taysha Gene Therapies
Jun 30, 2026
Maintained: Buy
Price Target: $14
Current: $6.57
Upside: +113.09%
Merck & Co.
Jun 23, 2026
Maintained: Buy
Price Target: $135
Current: $125.07
Upside: +7.94%
Pfizer
Jun 23, 2026
Maintained: Buy
Price Target: $34
Current: $24.25
Upside: +40.21%
Incyte
Jun 22, 2026
Upgraded: Hold
Price Target: $75 → $94
Current: $118.52
Upside: -20.69%
Novo Nordisk
Jun 22, 2026
Maintained: Hold
Price Target: $45
Current: $48.88
Upside: -7.94%
AbbVie
Jun 19, 2026
Maintained: Buy
Price Target: $258
Current: $249.91
Upside: +3.24%
Jun 17, 2026
Maintained: Hold
Price Target: $196
Current: $198.91
Upside: -1.46%
Jun 17, 2026
Maintained: Buy
Price Target: $7
Current: $7.29
Upside: -3.98%
Jun 14, 2026
Maintained: Buy
Price Target: $1,300
Current: $1,216.95
Upside: +6.82%
Jun 5, 2026
Maintained: Buy
Price Target: $145
Current: $55.14
Upside: +162.97%
Jun 2, 2026
Maintained: Buy
Price Target: $100
Current: $78.94
Upside: +26.68%
May 21, 2026
Maintained: Buy
Price Target: $730
Current: $667.95
Upside: +9.29%
May 13, 2026
Maintained: Hold
Price Target: $60
Current: $57.94
Upside: +3.56%
May 11, 2026
Maintained: Buy
Price Target: $26 → $34
Current: $26.41
Upside: +28.74%
May 11, 2026
Maintained: Hold
Price Target: $144
Current: $180.55
Upside: -20.24%
May 11, 2026
Maintained: Buy
Price Target: $128
Current: $92.98
Upside: +37.66%
May 5, 2026
Maintained: Buy
Price Target: $32 → $24
Current: $16.79
Upside: +42.94%
Apr 7, 2026
Maintained: Buy
Price Target: $160 → $174
Current: $134.84
Upside: +29.04%
Mar 18, 2026
Reiterated: Buy
Price Target: $70
Current: $57.94
Upside: +20.81%
Oct 13, 2025
Maintained: Buy
Price Target: $72 → $112
Current: $137.64
Upside: -18.63%
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $42.84
Upside: -
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $8.54
Upside: -
May 6, 2025
Rated: Hold
Price Target: n/a
Current: $4.29
Upside: n/a
Oct 23, 2024
Maintained: Buy
Price Target: €115.51 → €131.27
Current: $139.60
Upside: n/a
Aug 7, 2023
Rated: Hold
Price Target: n/a
Current: $9.89
Upside: n/a
May 9, 2023
Rated: Hold
Price Target: n/a
Current: $6.11
Upside: n/a
Aug 13, 2021
Maintained: Buy
Price Target: $30 → $27
Current: $5.90
Upside: n/a
Oct 16, 2020
Maintained: Hold
Price Target: €135.00 → €129.00
Current: $26.64
Upside: n/a
Aug 13, 2020
Reiterated: Sell
Price Target: $0.69 → $0.84
Current: $1.36
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $13 → $30
Current: $4.57
Upside: n/a
Feb 24, 2020
Maintained: Hold
Price Target: $169 → $220
Current: $30.59
Upside: n/a